Determination of the Potency of Drugs used in Treatment of Type2 Diabete (A Case Study of Taraba State Specialist Hospital Jalingo)

https://doi.org/10.46481/asr.2023.2.1.63

Authors

  • Charity Ebelechukwu Okorie Department of Mathematics and Statistics, Federal University, Wukari, Nigeria
  • Martin Afam Nwaokolo Department of Mathematics and Statistics, Federal University, Wukari, Nigeria

Keywords:

Diabetes, Insulin, Diabetic-drugs, Variance, Potency

Abstract

Diabetes is a medical condition in which the body cannot produce enough insulin to process the glucose in the blood. Type 2 diabetes is mostly diagnosed in order adults but it is increasingly seen in children, adolescent and younger adult. It is discovered that the rate at which patients are diagnosed of diabetes has been on the increase despite the series of diabetic drugs that are available. This prompted the researchers to carry out this research so as to determine the potency of drugs used in the treatment of type 2 diabetes. Data were collected from Specialist Hospital, Jalingo Taraba State. The data were used to obtain the relative potency and pooled variance as well as analyzing the potency of the diabetes drug. The result for the relative potency which is > 1 (1.62), means that the test preparation is less potent than the standard test preparation. We also observed that their confidence interval lies between (-12.88,17.05). Analyzing the significance difference between the standard test preparation and the test preparation, using the student t test we obtain calculated t=1.93 and the t value from the table=1.96. We conclude that since tcal=1.93 <ttab=1.96, we accept H1; and conclude that there is significant difference between Dji and Djk drugs (standard test preparation and test preparation respectively). This means that more effort is needed in the area of research for more diabetic drugs that will be highly effective in the treatment of diabetes.

Dimensions

American Diabetes Association (ADA), Diagnosis and Classification of Diabetes Mellitus Diabetes Care 35 (2012).

Centre for Disease Control and Prevention. About Underlying Cause of Death 1999–2015. CDC WONDER Database. http://wonder.cdc.gov/ucd-icd10.html. Updated December 2016. Accessed August 4, 2018.

American Diabetes Association (ADA), Diagnosis and Classification of Diabetes and delay by viral infection. Bull. Math. Biol. 78 (2010) 500.

A. I. Enagi, M. Bawa & A. M. Sani, “Mathematical Study of Diabetes and its Complication Using the Homotopy Perturbation Method,” International Journal of Mathematics and Computer Science 12 (2017) 43.

I. Kavakiotis, O. Tsave, A. Salifoglou, N. Maglaveras, I. Vlahavas, I. Chouvarda, Machine Learning and Data Mining Methods in Diabetes Research (2017).

N. E. L´opez-Palau & J. M. Olais-Govea, “Mathematical model of blood glucose dynamics by emulating the pathophysiology of glucose metabolism in type 2 diabetes mellitus”, Scientific Reports 10 (2020) 12697.

A. Makroglou, J. Li & Y. Kuang, “Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview”, Applied Numerical Mathematics 56 (2006) 559.

S. P. Borse, A. S. Chhipa, V. Sharma, D. P. Singh & M. Nivsarkar, “Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives”, Med PrincPract 30 (2021) 109.

B. Kwach, O. Ongati & R. Simwa, “Mathematical Model for Detecting Diabetes in the Blood”, Applied Mathematical Sciences 5 (2011) 279.

Mayo Clinic (2022); Type 1 Diabetes https://www.mayoclinic.org/diseases-conditions/type-1diabetes/symptoms-causes/syc-20353011

K. Nall, An overview of diabetes types and treatments (2021). https://www.medicalnewstoday.com/articles/323627

Centres for Disease Control and Prevention (CDC) (2017) cdc@service.govdelivery.com

S. V. Badescu, C. Tataru, L. Kobylinska, E. L. Georgescu, D. Zahu, A. M. Zagrean & L. Zagrean, “The Association between Diabetes and Depression”, J Med Life 9 (2016).

World Health Organization, Global Report on Diabetes (2016), Retrieved from https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257eng.pdf;jsessionid=CE1792D0E06B659C59D4046C6CC9BC07

World Health Organization, “Diabetes Mellitus: Report of a WHO Study Group. Geneva: WHO, 1985. Technical Report Series 727”, World Journal of Diabetes 7 (2016) 1.

I. Chervoneva, B. Freydin, B. Hipszer, T. V. Apanasovich & J. I. Joseph, “Estimation of Nonlinear Di erential Equation Model For Glucose–Insulin Dynamics In Type I Diabetic Patients Using Generalized Smoothing, The Annals of Applied Statistics 8 (2014) 886.

Hyuk Kang,1 Kyungreem Han2 and MooYoung Choi; Mathematical model for glucose regulation in the whole-body system, Islets 4 (2012) 84.

V. O. Akinsola & T. O. Oluyo, “Mathematical model of the complications and control diabetes mellitus”, International Journal of Mathematics and Computer Applications Research (UMCAR) 4 (2014) 1.

A. Bouteyab, E. H. Twizell, K. Achouayb & A. Chetouani, “A mathematical model for the burden of diabetes and its complications”, Biomedical Engineering 3 (2004) 1.

P. O. Aye, K. A. Adeyemo, A. S. Oke & A. E. Omotoye, “Analysis of Mathematical Model for the Dynamics of Diabetes Mellitus and Its Complications”, Applied Mathematics and Computational Intelligence 10 (2021) 51.

Published

2023-02-21

How to Cite

Okorie, C. E., & Nwaokolo , M. A. (2023). Determination of the Potency of Drugs used in Treatment of Type2 Diabete (A Case Study of Taraba State Specialist Hospital Jalingo). African Scientific Reports, 2(1), 63. https://doi.org/10.46481/asr.2023.2.1.63

Issue

Section

Original Research